Geode Capital Management
TBIO

Geode Capital Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Geode Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,642
Closed -$36.8K – 4635
2024
Q1 		$36.8K Hold
4,642
– – ﹤0.01% 4379
2023
Q4 		$33.4K Hold
4,642
– – ﹤0.01% 4437
2023
Q3 		$86.9K Buy
4,642
+597
+15% +$14.5K ﹤0.01% 4295
2023
Q2 		$115K Hold
4,045
– – ﹤0.01% 4283
2023
Q1 		$226K Hold
4,045
– – ﹤0.01% 3990
2022
Q4 		$91K Buy
4,045
+194
+5% +$5.27K ﹤0.01% 4433
2022
Q3 		$115K Sell
3,851
-856
-18% -$30.1K ﹤0.01% 4516
2022
Q2 		$152K Sell
4,707
-3,582
-43% -$247K ﹤0.01% 4412
2022
Q1 		$801K Buy
8,289
+1,503
+22% +$228K ﹤0.01% 3715
2021
Q4 		$1.32M Buy
6,786
+2,656
+64% +$413K ﹤0.01% 3571
2021
Q3 		$827K Buy
4,130
+3,338
+421% +$847K ﹤0.01% 3786
2021
Q2 		$313K Buy
+792
New +$280K ﹤0.01% 4146

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DWS
Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Geode Capital Management's TBIO Position: Q2 2024 in Review

Geode Capital Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 4,642 shares — an estimated $36.8K sold.

Geode Capital Management first reported a position in TBIO in Q2 2021 and held it in 12 quarters. The position peaked at $1.32M in Q4 2021. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

  • Geode Capital Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Geode Capital Management sold 4,642 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $36.8K.
  • Geode Capital Management first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Geode Capital Management's Telesis Bio, Inc. Common Stock position peaked at $1.32M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.